LBF20503HO05: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8123 | |LipidBank=DFA8123 | ||
|LipidMaps=LMFA03070006 | |LipidMaps=LMFA03070006 | ||
|SysName=11S- | |SysName=11S-Hydroxy- (cis-5,cis-8,trans-12,cis-14,cis-17) -eicosapentaenoic acid | ||
|Common Name=&&11S- | |Common Name=&&11S-Hydroxy- (5Z,8Z,12E,14Z,17Z) -eicosapentaenoic acid&& | ||
|UV Spectra= | |UV Spectra= lambda max: 236nm epsilon : 23,000 | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Symbol=11(S)-HEPE | |||
|Biological Activity=Almost all hydroxy-polyunsaturated fatty acids have been implicated in inflammatory reactions in humans. However, there have not been reports specifying the biological activity of 11(S)-HEPE. | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 07:36, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8123 |
| LipidMaps | LMFA03070006 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20503HO05 |
| 11S-Hydroxy- (5Z,8Z,12E,14Z,17Z) -eicosapentaenoic acid | |
|---|---|
| |
| Structural Information | |
| 11S-Hydroxy- (cis-5,cis-8,trans-12,cis-14,cis-17) -eicosapentaenoic acid | |
| |
| 11(S)-HEPE | |
| Formula | C20H30O3 |
| Exact Mass | 318.21949482599996 |
| Average Mass | 318.4504 |
| SMILES | C(CC=CC=C[C@H](CC=CCC=CCCCC(O)=O)O)=CCC |
| Physicochemical Information | |
| Almost all hydroxy-polyunsaturated fatty acids have been implicated in inflammatory reactions in humans. However, there have not been reports specifying the biological activity of 11(S)-HEPE. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 236nm ε : 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
